Association of A1C With Cardiovascular Disease and Metabolic Syndrome in Asian Indians With Normal Glucose Tolerance
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—This study examines the association of A1C with cardiovascular disease (CVD) risk factors, coronary artery disease (CAD), and metabolic syndrome in Asian Indians with normal glucose tolerance (NGT). RESEARCH DESIGN AND METHODS—This cross-sectional study recruited subjects from phase III of the Chennai Urban Rural Epidemiology Study (CURES), an epidemiological study in a representative population of Chennai (formerly Madras) in South India, conducted between January 2003 and June 2004. Included were 1,644 subjects with NGT, i.e., fasting plasma glucose <100 mg/dl (5.6 mmol/l) and 2-h postload plasma glucose <140 mg/dl (7.8 mmol/l). A1C was measured using the Biorad Variant machine. Metabolic syndrome was defined based on modified Adult Treatment Panel III guidelines. RESULTS—The mean ± SD A1C value in the study cohort was 5.5 ± 0.4%. A1C showed a significant association with BMI (β = 0.017, P < 0.001), systolic (β = 0.002, P = 0.028) and diastolic (β = 0.202, P = 0.017) blood pressure, waist circumference (β = 0.007, P < 0.001), serum cholesterol (β = 0.002, P < 0.001), triglycerides (β = 0.001, P < 0.001), LDL cholesterol (β = 0.002, P < 0.001), fasting insulin (β = 0.009, P < 0.001), and homeostasis model assessment of insulin resistance (β = 0.047, P < 0.001) after adjusting for age and sex. Regression analysis showed that A1C had a strong association with metabolic syndrome that persisted after adjusting for age and sex (odds ratio [OR] 2.9 [95% CI 2.08–4.00]; P < 0.001). A1C also had a strong association with CAD (2.6 [1.23–5.63]; P = 0.01), but the significance was lost when adjusted for age and sex. CONCLUSIONS—There is a strong association of A1C with prevalent CVD risk factors in Asian-Indian subjects with NGT.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These elevated and protracted postmeal lipid levels are common manifestations of insulin resistance and the metabolic syndrome (14).”
From Dietary Strategies for Improving Post-Prandial Glucose, Lipids, Inflammation, and Cardiovascular Health (2008) · cites this paper as [14]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s5 · Cited by 1,666
Cited by
Cognitive Dysfunction and Diabetes Mellitus
Kodl, C. T., & Seaquist, E. R. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0034 · Cited by 802
O’Keefe, J. H., Gheewala, N. M., & O’Keefe, J. O. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.016 · Cited by 497
INDIA TOWARDS DIABETES CONTROL: KEY ISSUES
Kumar, A., Goel, M. K., Jain, R. B., Khanna, P., & Chaudhary, V. (2013) · Australasian Medical Journal · doi:10.4066/amj.2013.1791 · Cited by 253
Azimi–Nezhad, M., Ghayour‐Mobarhan, M., Parizadeh, M., Safarian, M., Esmaeili, H., Parizadeh, S. M. J., Khodaee, G. H., Hosseini, J., Abasalti, Z., Hassankhani, B., et al. (2008) · PubMed · Cited by 226
Graduate Theses and Dissertations
Davis, M., Davis, K. J., & Dunagan, M. M. (2012) · Scientific Papers and Presentations · doi:10.1016/b978-0-12-384727-0.00006-9 · Cited by 164
Metadata
- Authors
- Dilley, J., Ganesan, A., Deepa, R., Deepa, M., Sharada, G., Williams, O. D., & Mohan, V.
- Affiliations
- Madras Diabetes Research Foundation (IN)
- University of Alabama at Birmingham (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-06-01
- Volume
- 30
- Issue
- 6
- Pages
- 1527-1532
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2027878956
- Cited by
- 58
- References
- 39
- Citations by year
- 2025: 1 · 2024: 1 · 2021: 1 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 5 · 2014: 2 · 2013: 7 · 2012: 8
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- World Health Organization
- University of Bristol
- Fogarty International Center (D43TW005816, D43-TW05816)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- HbA1c, cardiovascular risk, metabolic syndrome, coronary artery disease, normal glucose tolerance, Asian Indians, insulin resistance, fasting insulin, blood pressure, waist circumference, serum lipids, South India, diabetes prevention, prediabetes, cardiovascular risk stratification, glycemic targets
- MeSH terms
- Adult, Analysis of Variance, Blood Glucose, Cardiovascular Diseases, Coronary Disease, Cross-Sectional Studies, Female, Glycated Hemoglobin, Humans, India, Male, Middle Aged, Reference Values, Cohort Studies, Metabolic Syndrome, Asian People, Body Size
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.